| Authors: |
Manabe T; Department of Medicine, University of California, San Francisco, San Francisco, CA, USA. tadashi.manabe@ucsf.edu.; Department of Cellular and Molecular Pharmacology, University of California, San Francisco, San Francisco, CA, USA. tadashi.manabe@ucsf.edu.; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA, USA. tadashi.manabe@ucsf.edu., Bergo HC; Department of Medicine, University of California, San Francisco, San Francisco, CA, USA.; Department of Cellular and Molecular Pharmacology, University of California, San Francisco, San Francisco, CA, USA.; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA, USA., Li Q; Department of Medicine, University of California, San Francisco, San Francisco, CA, USA.; Department of Cellular and Molecular Pharmacology, University of California, San Francisco, San Francisco, CA, USA.; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA, USA., Wang TS; Kinnate Biopharma, San Diego, CA, USA., Severson P; Kinnate Biopharma, San Diego, CA, USA., Miller N; Kinnate Biopharma, San Diego, CA, USA., Lee C; Kinnate Biopharma, San Diego, CA, USA., Yay Donderici E; Guardant Health, Redwood City, CA, USA., Zhang N; Guardant Health, Redwood City, CA, USA., Wu W; Department of Medicine, University of California, San Francisco, San Francisco, CA, USA.; Department of Cellular and Molecular Pharmacology, University of California, San Francisco, San Francisco, CA, USA.; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA, USA., Chou YT; Department of Medicine, University of California, San Francisco, San Francisco, CA, USA.; Department of Cellular and Molecular Pharmacology, University of California, San Francisco, San Francisco, CA, USA.; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA, USA., Kerr DL; Department of Medicine, University of California, San Francisco, San Francisco, CA, USA.; Department of Cellular and Molecular Pharmacology, University of California, San Francisco, San Francisco, CA, USA.; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA, USA., Allegakoen P; Department of Medicine, University of California, San Francisco, San Francisco, CA, USA.; Department of Cellular and Molecular Pharmacology, University of California, San Francisco, San Francisco, CA, USA.; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA, USA., Grandinetti KB; Kinnate Biopharma, San Diego, CA, USA., Soroceanu L; Kinnate Biopharma, San Diego, CA, USA., Pelham RJ; Kinnate Biopharma, San Diego, CA, USA., Martin ES; Kinnate Biopharma, San Diego, CA, USA., Murphy EA; Kinnate Biopharma, San Diego, CA, USA., Khanna V; Division of Oncology, Department of Medicine, Stanford University School of Medicine, Stanford, CA, USA., Neal JW; Division of Oncology, Department of Medicine, Stanford University School of Medicine, Stanford, CA, USA., Chen CT; Division of Oncology, Department of Medicine, Stanford University School of Medicine, Stanford, CA, USA., Kato S; Division of Hematology and Oncology, University of California San Diego, Moores Cancer Center, La Jolla, CA, USA., Williams R; Kinnate Biopharma, San Diego, CA, USA., Bivona TG; Department of Medicine, University of California, San Francisco, San Francisco, CA, USA. trever.bivona@ucsf.edu.; Department of Cellular and Molecular Pharmacology, University of California, San Francisco, San Francisco, CA, USA. trever.bivona@ucsf.edu.; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA, USA. trever.bivona@ucsf.edu.; Chan-Zuckerberg Biohub, San Francisco, CA, USA. trever.bivona@ucsf.edu. |
